AzTrials
AzTrials

Urinary Incontinence, MixedEAMUINCT04531683

Effect of Electroacupuncture on Mixed Urinary Incontinence Among Women

A study testing electroacupuncture and life style counselling in people with Urinary Incontinence, Mixed, run by Guang'anmen Hospital of China Academy of Chinese Medical Sciences.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of the study is to assess the efficacy and safety of electroacupuncture on mixed urinary incontinence among women. Read more about this study

Who is it for?
Ages 35 to 75 years, women only
Conditions the study is for
Urinary Incontinence, Mixed
What is being tested?
electroacupuncture and life style counselling
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
460 participants
Where
No sites listed yet
Study dates
30 Oct 2020to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 to 75 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients are female and meet the diagnosis criteria of mixed urinary incontinence;
  • Patients are between age of 35 to 75 years old;
  • Positive in cough stress test;
  • Experience persistent urinary incontinence for at least 3 months, and at least one episode for each of stress and urgent urinary incontinence in 72 hours in baseline screening; and
  • Patients have signed informed consent form and are willing to participate the study voluntarily.
  • Patients will be included if all above 5 items are met.

Who cannot join

  • Patients have simple stress urinary incontinence, simple urgent urinary incontinence, overflowing urinary incontinence and neurogenic bladder, etc.;
  • Patients have uncontrolled urinary tract infection with urinary pain and urge;
  • Patients have urogenital system tumours and/or pelvic organ tumours;
  • Patients have taken drugs for urinary incontinence treatment or drugs possibly affect the function of lower urinary tract, or received non-drug treatment for urinary incontinence (i.e. electrical stimulation, bladder training, pelvic floor muscle training, and etc.) in the past one month;
  • Patients have history of surgeries for urinary incontinence and/or pelvic floor organs, including hysterectomy;
  • Patients have pelvic organ prolapse ≥ II degree;
Show all 16Show fewer
  • Patients have residual urine ≥ 100ml;
  • Patients have uncontrolled diabetes mellitus and severe hypertension;
  • Patients have diseases affecting lower urinary tract function, e.g. multiple sclerosis, Alzheimer's disease, Parkinson's disease, spinal cord injury, cauda equina injury and multiple system atrophy, etc.;
  • Patients have severe heart, lung, brain, liver, kidney and hematopoietic system diseases, mental disorders and cognitive dysfunction;
  • Patients are constrained or unable to complete movements like walking, going stairs up and down and running, etc.;
  • Patients have poor compliance;
  • Patients are at pregnancy, breastfeeding or postpartum period for less than 12 months;
  • Patients have cardiac pacemaker, metal allergy or strong fear of needle;
  • Patients are participants of other on-going studies; or
  • Patients have received acupuncture in the past 3 months. Patients will be excluded if they meet any of the above criteria.

Trial locations and contacts

No sites are listed yet.

Huan Chen, MPH, MD contact

+86 10 88002331

chen.huan@live.com

Zhishun Liu, PhD,MD contact

+86 10 88002331

liuzhishun@aliyun.com

About this study

Official title: Efficacy and Safety of Electroacupuncture on Mixed Urinary Incontinence Among Women: a Multi-centre, Randomised Controlled Trial

The purpose of the study is to assess the efficacy and safety of electroacupuncture on mixed urinary incontinence among women.

Read the detailed description

After being informed about the study and potential risk, all patients giving written informed consent form will be undergo a 1-week screening period to determine eligibility for study entry. Eligible patients will be randomly assigned to one of the three groups 1) electroacupuncture group: electroacupuncture will be provided to patients at BL33, BL35 and SP6 for 3 time per week for 8 weeks; 2) sham electroacupuncture group: sham electroacupuncture will be provided to patients at sham acupoints to BL33, BL35 and SP6 for 3 time per week for 8 weeks.The follow-up time for the first two groups are 24 weeks and life style counselling will be provided once when receiving the first acupuncture treatment(contents are the same as the life style counselling group). 3) life style counselling group: life style advice will be provided to patients at enrolment with content on drinking, diet, weight control, lung disease, urinary track infection control, and etc. Patients in this group will be followed up for 20 weeks. Primary and secondary outcome will be measured at 4, 8, 20, 32 weeks, respectively.

Being tested
electroacupuncture, sham electroacupuncture, life style counselling
Keywords
acupuncture, randomised controlled trial, sham acupuncture
Medical subject headings
Urinary Incontinence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • electroacupunctureOther

    same as described in experimental arm.

  • sham electroacupunctureOther

    same as described in sham comparator.

  • life style counsellingBehavioural

    life style counselling to patients with mixed urinary incontinence contains advice on daily drinking, caffeine intake, diet, constipation, exercise, heavy lifting, lung disease, urinary track infection and etc.

Study groups in NCT04531683
Study groupRoleWhat they receive
electroacupunctureExperimentalpatients will receive electroacupuncture at 3 acupoints (Bladder meridian of foot-taiyang 33 and 35(BL33 and BL35), and Spleen meridian of foot-taiyin 33(SP6)) 3 times/week for 8 weeks(24 times in total), followed with 24-weeks follow up. Disposable acupuncture needles with size of 0.30 × 75 mm will be used at BL 33 and BL 35, and needles with size of 0.30 × 40 mm at SP 6. Standardised electroacupuncture apparatuses will be used, and the stimulation will last for 30 minutes with a continuous wave of 20 Hz, and a current intensity of 2 to 6.5 mA at BL33 and BL 35, and 1 to 3.5 mA at SP6. Life style counselling will be provided to all patients and contents are as same as the life style counselling group.
Receives: Other: electroacupuncture; Behavioral: life style counselling
sham electroacupunctureSham comparatorpatient will receive sham electroacupuncture with the same frequency and amount as applied in the electroacupuncture group, as well as the follow-up period. Disposable acupuncture needles with size of 0.30 × 40 mm will be applied and penetrate the skin of patients for 2 to 3mm at sham acupoints to the 3 acupoints mentioned above. The stimulation will only last for 30-second with a very weak currency intensity and a continuous wave of 20 Hz. Life style counselling will be provided to all patients and contents are as same as the life style counselling group.
Receives: Other: sham electroacupuncture; Behavioral: life style counselling
life style counselling groupOtherpatients randomised to this group will receive a one-time life style counselling at the enrolment to improve their daily behaviour to expedite the recovery of their mixed urinary incontinence. Then the patients will be followed up for 20 weeks.
Receives: Behavioral: life style counselling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour incontinence episodes.

    data will be collected and evaluated by 72-hour incontinence episodes dairy

    Measured: at the 8th week after the last treatment

Secondary outcomes (10)
  1. the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour incontinence episodes

    data will be collected and evaluated by 72-hour incontinence episodes dairy

    Measured: at baseline, 4th, 20th and 32nd week

  2. the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour urgent incontinence episodes

    data will be collected and evaluated by 72-hour incontinence episodes dairy

    Measured: at baseline, 4th, 8th 20th and 32nd week

  3. the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour stress incontinence episodes

    data will be collected and evaluated by 72-hour incontinence episodes dairy

    Measured: at baseline, 4th, 8th, 20th and 32nd week

  4. the change from baseline in the amount of urine leakage measured by the 1-hour pad test

    data will be collected by 1-hour pad test

    Measured: at baseline, and the 8th week

  5. the change from baseline in the validated Chinese version of International Consultation on Incontinence Questionnaire-Short Form(ICIQ-SF) scores

    data will be collected via International Consultation on Incontinence Questionnaire-Short Form(ICIQ-SF). The total score(0-21scores) is an accumulated scores from question 1 to 3. The higher the total score is, the severer the incontinence is.

    Measured: at baseline, 4th, 8th, 20th and 32nd week

  6. the change from baseline in the validated Chinese version of the Overactive Bladder Questionnaire-Short Form scores

    data will be collected via the Overactive Bladder Questionnaire-Short Form. The higher the total score is, the severer the condition is.

    Measured: at baseline 4th, 8th, 20th and 32nd week

  7. number of patients with one or more life style change

    life style change, such as drinking, diet, weight control and etc, will be evaluated through questionnaire

    Measured: at the 4th, 8th, 20th and 32nd week

  8. incidence rate of any adverse events

    adverse event associated either with or without acupuncture will be documented as soon as it is reported in any centres. The type of conditions, time of on-set and relief, its relation with the intervention, treatment to the adverse event, whether the patient's participation is terminated or not due to the adverse event, etc.

    Measured: this is a case-based data reported by each centre from the start of treatment to the end of follow-up, up to 1 year and 4 months.

  9. patients' expectation to treatment

    patients will be asked about their expected effect of the treatment via question: In your expectation, how is your incontinence like in a two month time. Five choices will be provided 1) much better; 2) slightly better; 3) I don't know; 4) no change; 5) worse.

    Measured: at baseline

  10. blinding assessment

    patients will be asked whether they received electroacupuncture or sham acupuncture to assess the effect of blinding

    Measured: in 8th week after any acupuncture treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Aug 2020
  2. Study start30 Oct 2020 (estimated)
  3. Primary completion31 Dec 2021 (estimated)
  4. Study completion30 Jun 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Patients who sign the informed consent form and are eligible for the study entry at week 0 will be randomised to one of the three groups: electro-acupuncture group, sham electroacupuncture group and life style consultation group. The three group will be assessed in a paralleled manner, and patients in the first two groups will be treated 3 times per week for 8 weeks and followed up for 24 weeks, while patients in the third group will be provided with life style improvement information once and followed-up for 20 weeks.
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
460 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04531683
Sponsor's protocol ID
ZZ13-024-9
Acronym
EAMUI
Status last verified
Oct 2020
First submitted
20 Aug 2020
Last updated
8 Oct 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We cannot share IPD under current regulation of Human Genetic Resources Management in China.

Questions about this trial

What is this clinical trial studying?

A study testing electroacupuncture and life style counselling in people with Urinary Incontinence, Mixed, run by Guang'anmen Hospital of China Academy of Chinese Medical Sciences.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Oct 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Huan Chen, MPH, MD (+86 10 88002331, chen.huan@live.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the proportion of participants with at least 50 percent decrease from baseline in the mean 24-hour incontinence episodes. (time frame: at the 8th week after the last treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in